In addition, depletion of the MYT1 gene in cancer cells led to increased TMZ-induced cytotoxicity 67 which agrees with our findings where this gene expression was negatively associated with GBM survival with borderline significance ( Supplemental Table S3 ).
← all excerpts
Bioinformatic and clinical experimental assay uncovers resistance and susceptibility mechanisms of human glioblastomas to temozolomide and identifies new combined and individual survival biomarkers outperforming <i>MGMT</i> promoter methylation.
1
—
—